IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 239 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,076,000 | -3.5% | 184,731 | +10.7% | 0.01% | +28.6% |
| Q4 2021 | $3,187,000 | -15.0% | 166,941 | +9.8% | 0.01% | -22.2% |
| Q3 2021 | $3,748,000 | -4.5% | 152,001 | +0.8% | 0.01% | -10.0% |
| Q2 2021 | $3,925,000 | +84.6% | 150,839 | +124.6% | 0.01% | +66.7% |
| Q1 2021 | $2,126,000 | -70.5% | 67,145 | -56.7% | 0.01% | -70.0% |
| Q4 2020 | $7,196,000 | +2.9% | 155,090 | -27.0% | 0.02% | -20.0% |
| Q3 2020 | $6,993,000 | +61.4% | 212,417 | +34.6% | 0.02% | +47.1% |
| Q2 2020 | $4,332,000 | -25.5% | 157,822 | -18.7% | 0.02% | -46.9% |
| Q1 2020 | $5,811,000 | +58.0% | 194,138 | +46.1% | 0.03% | +60.0% |
| Q4 2019 | $3,679,000 | +850.6% | 132,894 | +524.4% | 0.02% | +900.0% |
| Q3 2019 | $387,000 | – | 21,283 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |